Functional Dependence Prior to ICU Admission is Associated with Worse Clinical and Functional Outcomes in Individuals

Darlisson B Paranhos1, Raquel Annoni2, Debora S Schujmann3

  • 1Master's Program in Physiotherapy, Federal University of Triângulo Mineiro and Federal University of Uberlândia, Uberaba, Brazil.

PubMed

Insights

Patients with COVID-19 admitted to the intensive care unit (ICU) who had low functional capacity (FC) prior to admission faced worse outcomes, including longer hospital stays and higher mortality. Survivors experienced functional decline during their ICU stay, linked to reduced mobility and muscle strength.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Rehabilitation Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) has led to significant intensive care unit (ICU) admissions.
  • Functional capacity (FC) prior to ICU admission may influence clinical outcomes in critically ill patients.
  • Understanding functional decline during ICU stays is crucial for patient recovery.

Purpose of the Study:

  • To investigate the association between pre-ICU functional capacity and clinical outcomes in COVID-19 patients.
  • To monitor changes in functional capacity from ICU admission to discharge.
  • To identify factors related to functional decline during the ICU stay.

Main Methods:

  • A prospective observational study involving 108 adult COVID-19 patients admitted to the ICU.
  • Functional capacity assessed using the Barthel index (BI) and mobility using the ICU mobility scale at admission and discharge.
  • Muscle strength measured by the Medical Research Council (MRC) scale and handgrip test at ICU discharge.

Main Results:

  • Pre-ICU functional status was associated with length of hospital stay (OR=1.05) and mortality (OR=5.27).
  • Patients experienced an average functional decline of 22.5 points on the BI during their ICU stay.
  • Lower mobility and muscle strength (MRC scale) at ICU discharge correlated with greater functional decline during hospitalization.

Conclusions:

  • Pre-ICU functional dependence in COVID-19 patients predicts poorer clinical outcomes, including increased hospitalization duration and mortality.
  • All surviving COVID-19 patients in the ICU experienced functional decline by the time of discharge, regardless of their initial status.
  • Reduced mobility and muscle strength upon ICU discharge are associated with a more significant functional decline experienced during the ICU stay.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
249
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
218
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
190
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
143
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
241